EBC Hosts Roundtable on Off-Label Use of Medicines
On the 10th of July, the European Brain Council (EBC) hosted an extremely insightful roundtable on “Ensuring the safe prescription of medicines off-label in Europe: what role for the European Union?”.
Over 30 leading healthcare and policy stakeholders shared insights on how to best address the existing challenges with off-label use. The event provided an opportunity to debate the European Commission’s study on off-label use released last February and a number of key questions about the path forward for off-label use regulation.
Speakers at the event included:
Frédéric Destrebecq, Executive Director of the European Brain Council
Aude L’hirondel, Unit B5 – Medicines: policy, authorisation and monitoring, DG Sante, European Commission
MEP Lieve Wierinck (BE, ALDE)
MEP José Inácio Faria (PT, EPP)
Marc Dooms, Senior orphan drug pharmacist, University Hospitals Leuven, and main author of the GOLUP Declaration
James Killick, Lawyer and regulatory expert, White & Case LLP